Surendra Rohtagi, a Kanpur-based medical expert, is on the verge of a breakthrough for a treatment for the acquired immunodeficiency syndrome (AIDS). The fight against the dreaded human immunodeficiency virus (HIV) has received a shot in the arm, thanks to this Indian doctor. Rohtagi was recently granted a patent for his new drug for treating AIDS by the US Patent and Trade Office.
The drug consists of two multi-component Ayurvedic drugs -- Livzon and Imminex -- in predetermined proportions. It works by enhancing the patient's immunity by selective use of herbal drugs, simultaneously stimulating the body's physiological functions.
With the correction of immunodeficiency by the new therapy, the body's own defensive forces selectively kill the infecting germs and the AIDS symptoms disappear in the patient. The drug can be administered in several forms: aqueous extracts, hard gelatine capsules, or mixed in syrup. According to Rohtagi, one advantage of this new treatment is the absence of adverse drug reactions that usually accompany the therapies currently employed.